位置:首页 > 蛋白库 > PROT_BACS1
PROT_BACS1
ID   PROT_BACS1              Reviewed;         145 AA.
AC   J9ZXD8;
DT   12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2012, sequence version 1.
DT   25-MAY-2022, entry version 16.
DE   RecName: Full=Polytheonamide B {ECO:0000303|PubMed:22983711};
DE   AltName: Full=Proteusin {ECO:0000303|PubMed:22983711};
DE   Flags: Precursor;
GN   Name=poyA {ECO:0000303|PubMed:22983711};
OS   Bacterium symbiont subsp. Theonella swinhoei (strain pTSMAC1).
OC   Bacteria.
OX   NCBI_TaxID=1221190;
RN   [1] {ECO:0000312|EMBL:AFS60639.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], EXPRESSION IN E.COLI, D-AMINO ACID AT
RP   VAL-102; ALA-104; VAL-106; VAL-110; ASN-112; ASN-118; VAL-120; ASN-124;
RP   ASN-126; VAL-128; ASN-130; ASN-132; ASN-134; ASN-136; SER-138; ASN-140;
RP   ASN-142 AND THR-144, METHYLATION AT ILE-99; VAL-101; VAL-102; VAL-103;
RP   VAL-105; VAL-106; VAL-110; ASN-112; THR-113; VAL-117; ASN-118; GLN-119;
RP   ASN-124; ASN-126; VAL-127; ASN-130; ASN-132; ASN-134; ASN-136 AND MET-141,
RP   AND HYDROXYLATION AT VAL-120; ASN-126; VAL-128 AND ASN-134.
RX   PubMed=22983711; DOI=10.1126/science.1226121;
RA   Freeman M.F., Gurgui C., Helf M.J., Morinaka B.I., Uria A.R., Oldham N.J.,
RA   Sahl H.G., Matsunaga S., Piel J.;
RT   "Metagenome mining reveals polytheonamides as posttranslationally modified
RT   ribosomal peptides.";
RL   Science 338:387-390(2012).
CC   -!- FUNCTION: Antimicrobial peptide active against Gram-positive bacteria
CC       (MIC=4->125 ug/ml) (PubMed:22983711). May act by forming transmembrane
CC       ion channels, since the peptide rapidly depolarizes the bacterial
CC       cytoplasmic membrane, simultaneously decreasing the membrane potential
CC       and intracellular potassium contents (PubMed:22983711).
CC       {ECO:0000269|PubMed:22983711}.
CC   -!- PTM: Epimerization of most, and perhaps all, L- to D-amino acids is
CC       catalyzed by PoyD, when PoyA and PoyD are coexpressed in E.coli.
CC       {ECO:0000269|PubMed:22983711}.
CC   -!- PTM: N-methylations are catalyzed by PoyE, when PoyA and PoyE are
CC       coexpressed in E.coli. {ECO:0000269|PubMed:22983711}.
CC   -!- PTM: To obtain 2-oxo-5,5-dimethylhexanoate, Thr-97 is firstly
CC       dehydrated by PoyF (PubMed:22983711). The second step possibly
CC       corresponds to methylation by PoyB/C, and the third step may be a
CC       cleavage by PoyH/J (Probable). {ECO:0000269|PubMed:22983711,
CC       ECO:0000305|PubMed:22983711}.
CC   -!- MISCELLANEOUS: The name 'proteusin' is inspired by Proteus, a Greek
CC       shape-shifting sea god. {ECO:0000305|PubMed:22983711}.
CC   -!- MISCELLANEOUS: Compared to polytheonamide B, polytheonamide A has an
CC       additional sulfoxide moiety at Met-141, which arises from spontaneous
CC       oxidation during polytheonamide isolation.
CC       {ECO:0000305|PubMed:22983711}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JX456532; AFS60639.1; -; Genomic_DNA.
DR   AlphaFoldDB; J9ZXD8; -.
DR   TCDB; 1.D.24.1.1; the marine sponge polytheonamide b (ptb) family.
DR   GO; GO:0003824; F:catalytic activity; IEA:InterPro.
DR   GO; GO:0046914; F:transition metal ion binding; IEA:InterPro.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0006807; P:nitrogen compound metabolic process; IEA:InterPro.
DR   Gene3D; 3.90.330.10; -; 1.
DR   InterPro; IPR036648; CN_Hdrase_a/SCN_Hdrase_g_sf.
DR   InterPro; IPR022513; TOMM_pelo.
DR   SUPFAM; SSF56209; SSF56209; 1.
DR   TIGRFAMs; TIGR03793; TOMM_pelo; 1.
PE   1: Evidence at protein level;
KW   Antibiotic; Antimicrobial; D-amino acid; Hydroxylation; Methylation.
FT   PROPEP          1..96
FT                   /evidence="ECO:0000305|PubMed:22983711"
FT                   /id="PRO_0000450586"
FT   CHAIN           97..145
FT                   /note="Polytheonamide B"
FT                   /evidence="ECO:0000305|PubMed:22983711"
FT                   /id="PRO_0000450587"
FT   MOD_RES         97
FT                   /note="2-oxo-5,5-dimethylhexanoate"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         99
FT                   /note="3-methylisoleucine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         101
FT                   /note="3-methylvaline"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         102
FT                   /note="3-methyl-D-valine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         103
FT                   /note="3-methylvaline"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         104
FT                   /note="D-alanine (Ala)"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         105
FT                   /note="3-methylvaline"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         106
FT                   /note="3-methyl-D-valine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         110
FT                   /note="3-methyl-D-valine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         112
FT                   /note="N4-methyl-D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         113
FT                   /note="3-hydroxyvaline (Thr)"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         117
FT                   /note="3-methylvaline"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         118
FT                   /note="N4-methyl-D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         119
FT                   /note="(3S)-3-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         120
FT                   /note="3-hydroxy-D-valine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         124
FT                   /note="N4-methyl-D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         126
FT                   /note="(3R)-N4-methyl-3-hydroxy-D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         127
FT                   /note="3-methylvaline"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         128
FT                   /note="3-hydroxy-D-valine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         130
FT                   /note="N4-methyl-D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         132
FT                   /note="N4-methyl-D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         134
FT                   /note="(3R)-N4-methyl-3-hydroxy-D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         136
FT                   /note="N4-methyl-D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         138
FT                   /note="D-serine (Ser)"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         140
FT                   /note="D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         141
FT                   /note="3,3-dimethylmethionine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         142
FT                   /note="D-asparagine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
FT   MOD_RES         144
FT                   /note="D-threonine"
FT                   /evidence="ECO:0000269|PubMed:22983711"
SQ   SEQUENCE   145 AA;  15425 MW;  A01FD18DAF5944EE CRC64;
     MADSDNTPTS RKDFETAIIA KAWKDPEYLR RLRSNPREVL QEELEALHPG AQLPDDLGIS
     IHEEDENHVH LVMPRHPQNV SDQTLTDDDL DQAAGGTGIG VVVAVVAGAV ANTGAGVNQV
     AGGNINVVGN INVNANVSVN MNQTT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024